Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1.98%
operating margin TTM
-1.92%
revenue TTM
50.31 Million
revenue per share TTM
3.62$
valuation ratios | |
|---|---|
| pe ratio | -66.63 |
| peg ratio | 0.40 |
| price to book ratio | 18.72 |
| price to sales ratio | 1.25 |
| enterprise value multiple | 165.91 |
| price fair value | 18.72 |
profitability ratios | |
|---|---|
| gross profit margin | 48.0% |
| operating profit margin | -1.92% |
| pretax profit margin | -1.56% |
| net profit margin | -1.98% |
| return on assets | -4.35% |
| return on equity | -29.56% |
| return on capital employed | -16.13% |
liquidity ratios | |
|---|---|
| current ratio | 0.96 |
| quick ratio | 0.96 |
| cash ratio | 0.24 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 80.94 |
| days of payables outstanding | 81.54 |
| cash conversion cycle | -0.60 |
| receivables turnover | 4.51 |
| payables turnover | 4.48 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 1.17 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.54 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.97 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.36 |
| cash per share | 0.35 |
| operating cash flow per share | -0.32 |
| free cash flow operating cash flow ratio | 1.13 |
| cash flow coverage ratios | -0.97 |
| short term coverage ratios | -2.80 |
| capital expenditure coverage ratio | -7.93 |
Frequently Asked Questions
When was the last time Champions Oncology, Inc. (NASDAQ:CSBR) reported earnings?
Champions Oncology, Inc. (CSBR) published its most recent earnings results on 27-07-2026.
What is Champions Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Champions Oncology, Inc. (NASDAQ:CSBR)'s trailing twelve months ROE is -29.56%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Champions Oncology, Inc. (CSBR) currently has a ROA of -4.35%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CSBR's net profit margin stand at?
CSBR reported a profit margin of -1.98% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CSBR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.96 in the most recent quarter. The quick ratio stood at 0.96, with a Debt/Eq ratio of 1.17.